Moving towards composite biomarkers for disease management

Moving towards composite biomarkers for disease management

Moving towards composite biomarkers for disease management Relevant and reliable biomarkers are the key to implementing personalised medicine in clinical practice. While single biomarkers have guided the treating physicians and researchers for decades, scientific...
eNose technology, a promising diagnostic tool for ILD

eNose technology, a promising diagnostic tool for ILD

eNose technology, a promising diagnostic tool for ILD Interstitial lung diseases (ILD) are a diverse group of over 200 different lung diseases that are classified together because of their similarities in e.g. clinical, radiological and pathological features [i]....
10 questions for Peter Sterk, Scientific Adviser

10 questions for Peter Sterk, Scientific Adviser

10 questions for Peter Sterk, Scientific Adviser Peter Sterk has launched exhaled breath analysis by eNose in various clinical settings. Peter is a biomedical scientist (MD with a PhD in Physiology) trying to incorporate novel biological information into the diagnosis...
Exhaled breath analysis for prediction of response to Immunotherapy

Exhaled breath analysis for prediction of response to Immunotherapy

Exhaled breath analysis for prediction of response to Immunotherapy The emergence of cancer immunotherapy has revolutionized the treatment paradigm for advanced cancers across a wide range of tumor types and has brought hope to thousands of patients suffering from...
10 questions for Michael Rutgers, Lung Foundation Netherlands

10 questions for Michael Rutgers, Lung Foundation Netherlands

10 questions for Michael Rutgers, Lung Foundation Netherlands One of Michael Rutgers’ aims is to help prevent smoking in children and young people and help adults to quit smoking. Michael is the Managing Director of the Lung Foundation Netherlands, passionately...